Abstract
Background: Prenatal environmental factors such as maternal adiposity may influence the risk of offspring autism spectrum disorders (ASD), though current evidence is inconsistent. The objective of this study was to assess the relationship of parental BMI and gestational weight gain (GWG) with risk of offspring ASD in a population-based cohort study using family-based study designs.
Methods: The cohort was based in Stockholm County, Sweden, including 333 057 individuals born 1984–2007, of whom 6420 were diagnosed with an ASD. We evaluated maternal body mass index (BMI) at first antenatal visit, GWG and paternal BMI at the time of conscription into the Swedish military as exposures using general estimating equation (GEE) models with logit link.
Results: At the population level, maternal overweight/obesity was associated with increased risk of offspring ASD [odds ratio (OR)25 ≤ BMI < 30 1.31, 95% confidence interval = 1.21–1.41; ORBMI ≥ 30 1.94, 1.72–2.17], as was paternal underweight (ORBMI < 18.5, 1.19, 1.06–1.33) and obesity (ORBMI ≥ 30 1.47, 1.12–1.92) in mutually adjusted models. However, in matched sibling analyses, the relationship between elevated maternal BMI and ASD risk was not apparent. GWG had a U-shaped association with offspring ASD at the population level (ORinsufficient 1.22, 1.07–1.40; ORexcessive 1.23, 1.08–1.40). Matched sibling analyses were suggestive of elevated risk with excessive GWG (ORinsufficient 1.12, 0.68–1.84; ORexcessive 1.48, 0.93–2.38).
Conclusions: Whereas population-level results suggested that maternal BMI was associated with ASD, sibling analyses and paternal BMI analyses indicate that maternal BMI may also be a proxy marker for other familial risk factors. Evidence is stronger for a direct link between GWG and ASD risk.
Keywords: Autism spectrum disorders, body mass index, pregnancy, gestational weight gain
Key Messages
Maternal adiposity during pregnancy has been linked to increased risk of offspring autism spectrum disorders (ASD), but the evidence has been inconsistent.
This study found evidence that higher maternal body mass index (BMI) at pregnancy baseline and paternal BMI at age 18 were independently associated with increased risk of ASD in offspring. However, sibling analyses suggested that the maternal BMI-ASD association may be affected by residual confounding.
Insufficient or excessive maternal gestational weight gain both were associated with increased risk of ASD, and this was supported by sibling analyses.
Introduction
Rates of overweight and obesity have dramatically increased in recent decades,1 paralleling an increase in the prevalence of autism spectrum disorders (ASD). Some reports suggest that maternal obesity in early pregnancy2,3 and excessive weight gain during pregnancy2,4 increase risk of offspring ASD. Other studies have raised the possibility that associations between maternal body mass index (BMI) and ASD risk may not be causal but are instead due to familial confounding.4,5 In other words, the same genetic or environmental factors shared among family members that predispose mothers to high BMI may also predispose offspring to ASD. However, all of these studies featured <1000 cases of ASD, limiting statistical power.
The aim of this study was to explore the relationship of both maternal baseline BMI and gestational weight gain (GWG) with risk of ASD in the offspring in the largest study to date. In addition, we used two family-based study designs, paternal-offspring comparisons and matched sibling comparisons,6–8 to explore the potential for alternative mechanisms to explain the relationship between maternal BMI and offspring ASD risk. We used matched sibling comparisons to do the same for the relationship between GWG and offspring ASD risk.
Methods
Study population
Our study is nested within the Stockholm Youth Cohort (SYC), a prospective register-based cohort consisting of all individuals born 1984–2007 and resident in Stockholm County for ≥4 years.9,10 Children who were adopted (7266), from a multiple birth (13 919) or born outside Sweden (60 020) were excluded. Exposure, outcome and covariate data were extracted from national and regional computerized data registers, described elsewhere.9,10 This study was approved by the regional ethical review board for Karolinska Institutet (DNR 2010/1185‐31/5). Informed consent was not required for the analysis of anonymized register data.
ASD diagnosis
ASD case status as of 31 December 2011 was ascertained in a procedure covering all potential pathways to ASD care and diagnosis in Stockholm County, using ICD-9, ICD-10, and DSM-IV codes.9 ASD was subtyped by absence or presence of comorbid intellectual disability (ID), defined as IQ < 70. A medical records review found that 96.0% of register-identified ASD cases were consistent with an ASD diagnosis.9
Exposure variables: parental BMI and GWG
We used maternal weight at the first antenatal visit as a proxy for pre-pregnancy weight. The Medical Birth Register (MBR) contains objectively measured maternal weight and height data recorded by midwives at the first antenatal visit, at median 10.6 [interquartile range (IQR): 9.0–12.6] weeks.11 These endpoints were not captured in 1990–91 and were available for 75.7% of the mother/child pairs otherwise (Figure 1). Weights <40 kg or >140 kg were censored, as were heights <140 cm and >200 cm. The proportion of overweight and obese mothers included in our study agrees with other longitudinal reports in Sweden during the same time period (Figure 2).12,13 Maternal baseline BMI values were categorized by standard convention: underweight (BMI < 18.5), normal (18.5 ≤ BMI < 25), overweight (25 ≤ BMI < 30), and obese (BMI ≥ 30).14 Maternal metabolic conditions (pre-gestational hypertension, pre-gestational diabetes, pre-eclampsia and gestational diabetes) were defined according to ICD diagnostic codes within the MBR or the National Patient Register (Supplementary Table 1, available as Supplementary data at IJE online).
Figure 1.
Derivation of the sample.
Figure 2.
The prevalence of overweight and obesity in Swedish women and men over time. (A) Comparison of the prevalence of overweight and obesity among mothers of children in the SYC with other reported values in Swedish women. Berg et al.12 measured weight and height for 605 Swedish women aged 25–34 during the years 1985–2002. Brynhildsen et al.13 collected maternal weight and height at first prenatal visit data from medical records of 4430 women delivering at Swedish hospitals. (B) Prevalence of overweight and obesity among fathers of children in the SYC, based on BMI data collected at the time of conscription into the Swedish military at the age of 18.
Of the mother/child pairs with maternal baseline BMI data, 34% also had maternal weight at the time of delivery recorded within the MBR, similar to previous studies using MBR data.15 For these mothers, GWG categories were defined as ‘ideal’, ‘insufficient’ or ‘excessive’ based on Institute of Medicine recommendations for each BMI category (underweight: 12.5–18 kg; normal weight 11.5–16 kg; overweight 7–11.5 kg; obese: 5–9 kg).16
Paternal BMI data from the time of conscription in the Swedish military (at age 18) were available for 66.1% of the children for whom maternal BMI data were available (Figure 1).
Other covariates
Sociodemographic data were extracted for the year before the birth of the index child.17 Disposable family income measurements account for all sources of income and are adjusted for family size and inflation. Parental educational achievement (highest of mother or father) was categorized as ≤9 years of schooling, 10–12 years, or >12 years.17 Maternal migrant status was categorized as born in Sweden or outside. Parity was categorized as primiparous or not. Parental history of psychiatric inpatient treatment before the birth of the index child (yes/no) was extracted from the national inpatient register. Following our previous work,9,18 birth year, maternal age and paternal age were centered and included in models as quadratic terms, to accommodate non-linear relationships between ASD risk and these factors. Gestational week at first antenatal visit was recorded in the MBR from mid 1995 onwards for 93–98% of women every year (Table 1).
Table 1.
Characteristics of the Stockholm Youth Cohort, born 1984–2007, shown for each sub-cohort in the current analysis
| Full cohort (333 057) | Parental BMI cohort (220 371) | Full sibling cohort (114 223) | Matched sibling cohort (4775) | GWG cohort (113 822) | |
|---|---|---|---|---|---|
| Prevalence, % (ASD with ID, %/ASD without ID, %) | |||||
| Full cohort | 1.9% (0.5%/1.4%) | 1.9% (0.4%/1.5%) | 2.0% (0.5%/1.5%) | 45% (11%/34%) | 1.7% (0.4%/1.3%) |
| Prevalence by birth cohort, % (ASD with ID, %/ASD without ID, %) | |||||
| Born 1984–89 (22–27 years old) | 1.5% (0.5%/1.0%) | 1.4% (0.4%/1.0%) | 1.5% (0.5%/1.0%) | – | 1.5% (0.4%/1.1%) |
| Born 1992 –96 (15–19 years old) | 2.5% (0.7%/1.8%) | 2.5% (0.6%/1.9%) | 2.5% (0.7%/1.8%) | – | 2.4% (0.6%/1.8%) |
| Born 1997–2001 (10–14 years old) | 2.5% (0.6%/1.9%) | 2.5% (0.4%/2.1%) | 2.6% (0.7%/1.9%) | – | 2.6% (0.5%/2.1%) |
| Born 2002–07 (4–9 years old) | 1.3% (0.3%/1.0%) | 1.2% (0.2%/1.0%) | 1.4% (0.3%/1.1%) | – | 1.5% (0.4%/1.1%) |
| Maternal BMI, mean (SD) | 23.2 (3.8) | 23.0 (3.6) | 25.1 (3.5) | 25.8 (4.2) | 22.6 (3.6) |
| Paternal BMI, mean (SD) | 21.5 (2.5)* | 21.5 (2.5) | 21.7 (2.6)* | 21.6 (2.7)* | 21.4 (2.5)* |
| Gestational weight gain (GWG), mean (SD) | 13.9 (4.9)* | 14.0 (4.8)* | 13.9 (5.3)* | 13.9 (5.5)* | 13.9 (4.9) |
| Male, % | 51.2% | 51.3% | 51.4% | 60.1% | 51.1% |
| Maternal age, mean (SD) | 29.9 (5.1) | 29.9 (4.9) | 30.0 (4.9) | 30.0 (5.1) | 29.1 (5.2) |
| Paternal age, mean (SD) | 32.8 (6.2) | 31.9 (5.3) | 32.9 (6.0) | 33.0 (6.2) | 32.0 (6.3) |
| Primiparous, % | 45.4% | 47.8% | 37.8% | 34.3% | 47.3% |
| Mothers born outside Sweden, % | 24.0% | 10.5% | 25.1% | 23.9% | 22.1% |
| Maternal history of inpatient psychiatric care, % | 3.1% | 3.0% | 2.5% | 4.1% | 2.8% |
| Paternal history of inpatient psychiatric care, % | 2.8% | 2.5% | 2.4% | 3.4% | 2.5% |
| Parents with >12 years’ schooling, % | 53.1% | 56.0% | 52.7% | 49.5% | 49.1% |
| Parental income quintile 1 (lowest), % | 13.8% | 7.2% | 13.7% | 14.4% | 15.9% |
| Gestational week at first antenatal visit, mean (SD) | 11.4 (4.5)a | 11.2 (4.2)a | 11.3 (4.1)a | 11.2 (4.0)a | 11.5 (4.6)a |
aIndicates that data were not available for all members of cohort.
Statistical Analyses
BMI and ASD
Analyses were conducted using Stata/MP 12.1 (College Station, TX). Categorical analyses used normal BMI as the referent category. Continuous analyses used restricted cubic spline models with five knots and xbrcspline post-estimation,19 with BMI = 21 as the referent. Restricted cubic spline models flexibly fit relationships between variables that are non-linear in nature. We used general estimating equation (GEE) models with logit link clustered on maternal identification number to provide robust standard errors. Models were adjusted for sex, birth year, parity, maternal age, paternal age, maternal country of birth, parental education, income and parental psychiatric history. Covariates were chosen a priori based on reported associations with ASD.17,18,20–22 Maternal and paternal BMI were considered separately and in a mutually adjusted model. We repeated these analyses stratified by ASD with and without ID. GEE models adjusted as described above were used to evaluate the relationship between maternal metabolic conditions and ASD; the analyses were repeated including adjustment for maternal BMI category.
GWG and ASD
GWG was analysed as both a categorical and continuous variable with GEE as above. Categorical variables were analysed with ideal GWG as the referent group. For continuous analysis, we used restricted cubic spline models with five knots, with GWG = 14 kg as the referent. Models were adjusted for maternal BMI category, gestational age at birth, sex, birth year, parity, maternal age, paternal age, maternal country of birth, socioeconomic status (SES) and parental psychiatric history. Outcomes of any ASD and ASD with and without ID were considered. To distinguish the potential effects of GWG from baseline BMI, we repeated the analysis, restricting the sample to mothers who began pregnancy with a normal BMI.
Sibling analyses
We used a sibling comparison design to assess whether observed associations of baseline BMI and GWG with ASD might be due to residual confounding by familial factors. Matched sibling comparisons were carried out using conditional logistic regression models, grouped on maternal identification number, and adjusted for sex, birth year, sibling birth order and maternal and paternal age at time of birth. Informed from earlier models, we parameterized maternal BMI as a continuous variable for BMI values ≥21, in addition to categorization.
Sensitivity analyses
Given differences in ASD risk factors (such as income distribution and maternal migration status) between those with a paternal BMI measurement and those without (see Table 1), we repeated the analysis of maternal BMI in the full cohort with maternal baseline BMI measures. Gestational week at first antenatal visit might influence both maternal weight and offspring health; therefore, we repeated analysis of maternal BMI including gestational week at the time of the first visit. To explore residual confounding by parental psychiatric illness, we examined a more inclusive indicator of parental psychiatric service use including both inpatient and outpatient psychiatric history. To examine cohort effects, we stratified the sample on the median birth year (1997). For paternal BMI measures, sensitivity analyses included additional adjustment for paternal IQ measured at the time of conscription, adjustment for any parental psychiatric service use (inpatient or outpatient), and stratification on the median birth year (1997).
Results
Study sample
The final sample included 333 057 individuals, born to 176 850 mothers; 6420 offspring had an ASD.
Characteristics of each sub-cohort in this analysis are presented in Table 1. Compared with children with maternal BMI data but lacking paternal BMI data, children with paternal BMI data were more likely to be born to a mother who was born in Sweden and less likely to have low socioeconomic status (Table 1). Otherwise, the sub-cohorts were generally similar, except where differences were expected (e.g. a higher prevalence of ASD and a lower proportion of primiparous mothers in the matched sibling cohort). Mother/child pairs with BMI data were similar to those without BMI data (Supplementary Table 2, available as Supplementary data at IJE online). Mother/child pairs with GWG data were similar to those without GWG data, except for birth year of the index child (Supplementary Table 3, available as Supplementary data at IJE online). GWG data capture varied year-to-year and tended to be better in earlier part of the cohort.
Maternal BMI and ASD risk
In categorical analysis, risk of ASD was elevated for overweight and obese mothers compared with normal weight mothers (Table 2). In continuous analysis, we observed a dose-response relationship between maternal BMI > 21 and increasing risk for ASD (Figure 3). Adjusting for paternal BMI did not alter the relationship between maternal BMI and ASD (Table 2). Similar risk patterns were observed after stratifying ASD with and without intellectual disability (Figure 3; Table 2). The observed dose-response relationship between maternal BMI > 21 and ASD was unchanged in sensitivity analyses (Supplementary Figure 1, available as Supplementary data at IJE online).
Table 2.
Odds ratios and 95% confidence intervals for the association between parental BMI and autism spectrum disorders (all ASD, and with or without comorbid intellectual disability) for children born in Sweden 1984–2007 with BMI data available for both parents (220 317 from 148 296 mothers)
| Maternal BMI at first antenatal visit |
Paternal BMI at conscription (age ∼ 18) |
|||||||
|---|---|---|---|---|---|---|---|---|
| No. cases/non-cases | ORa | Adjusted ORb | Mutually adjusted ORc | No. cases/non-cases | ORa | Adjusted ORb | Mutually adjusted ORc | |
| Normal (BMI ≥ 18.5 & < 25), reference category | ||||||||
| ASD | 2755/159 480 | – | – | – | 3381/182 393 | – | – | – |
| ASD with ID | 548/159 480 | – | – | – | 660/182 393 | – | – | – |
| ASD without ID | 2207/159 480 | – | – | – | 2721/182 393 | – | – | – |
| Underweight (BMI < 18.5) | ||||||||
| ASD | 165/9024 | 1.10 (0.94 – 1.29) | 1.05 (0.90 –1.24) | 1.05 (0.90 – 1.24) | 382/16 557 | 1.23 (1.10 – 1.38) | 1.20 (1.08 – 1.34) | 1.19 (1.06 – 1.33) |
| ASD with ID | 43/9024 | 1.33 (0.97 – 1.82) | 1.28 (0.94 – 1.76) | 1.29 (0.94 – 1.76) | 74/16 557 | 1.19 (0.93 – 1.52) | 1.16 (0.90 – 1.48) | 1.15 (0.90 – 1.47) |
| ASD without ID | 122/9024 | 1.04 (0.86 – 1.25) | 0.99 (0.82 – 1.19) | 0.99 (0.82, 1.19) | 308/16 557 | 1.25 (1.10 – 1.41) | 1.21 (1.07 – 1.37) | 1.20 (1.06 – 1.36) |
| Overweight (BMI ≥ 25 & < 30) | ||||||||
| ASD | 864/37 227 | 1.34 (1.24 – 1.45) | 1.31 (1.21 – 1.42) | 1.31 (1.21 – 1.41) | 334/15 429 | 1.18 (1.05 – 1.33) | 1.13 (1.00 – 1.27) | 1.07 (0.95 – 1.20) |
| ASD with ID | 159/37 227 | 1.29 (1.08 – 1.55) | 1.25 (1.04 – 1.50) | 1.24 (1.03 – 1.48) | 66/15 429 | 1.20 (0.93 – 1.56) | 1.15 (0.89 – 1.49) | 1.10 (0.85 – 1.43) |
| ASD without ID | 705/37 227 | 1.35 (1.24 – 1.48) | 1.33 (1.22 – 1.45) | 1.32 (1.21 – 1.45) | 268/15 429 | 1.18 (1.04 – 1.35) | 1.12 (0.9 – 1.28) | 1.06 (0.93 – 1.21) |
| Obese (BMI ≥ 30) | ||||||||
| ASD | 375/10 481 | 2.07 (1.85 – 2.32) | 1.97 (1.76 – 2.21) | 1.94 (1.72 – 2.17) | 62/1833 | 1.90 (1.46 – 2.48) | 1.69 (1.30 – 2.20) | 1.47 (1.12 – 1.92) |
| ASD with ID | 65/10 481 | 1.97 (1.51 – 2.55) | 1.83 (1.40 – 2.38) | 1.77 (1.35 – 2.31) | 15/1833 | 2.49 (1.48 – 4.19) | 2.23 (1.33 – 3.78) | 1.99 (1.18 – 3.36) |
| ASD without ID | 310/10 481 | 2.11 (1.86 – 2.39) | 2.01 (1.77 – 2.28) | 1.98 (1.74 – 2.25) | 47/1833 | 1.77 (1.31 – 2.40) | 1.57 (1.16 – 2.12) | 1.35 (1.0 – 1.83) |
aGEE model including maternal or paternal BMI as appropriate, adjusted only for sex and birth year of the child.
bGEE model including maternal or paternal BMI as appropriate, adjusted for sex, birth year of the child, parity, maternal age at the time of birth, paternal age at the time of birth, maternal country of birth, SES factors and parental history of psychiatric treatment.
cGEE model including both maternal BMI and paternal BMI, and covariates from the previous model.
Figure 3.
Risk of ASD in relation to maternal baseline BMI and paternal BMI (age 18). The solid line indicates odds ratios estimated using a restricted cubic spline model with five knots. BMI of 21 was used as the referent value. The 95% confidence interval is represented as grey bands. The model was adjusted for sex, birth year of the child, parity, maternal age, paternal age, maternal country of birth, SES factors and parental history of psychiatric treatment. OR estimates from a categorical model, similarly adjusted, are shown for comparison (dotted line; see Table 2). Results are shown for all ASD cases (A, B), for ASD cases with ID (C, D), and for ASD cases without ID (E, F).
Pre-eclampsia, pre-gestational diabetes and gestational diabetes were associated with an increased risk of ASD in the offspring (Supplementary Table 4, available as Supplementary data at IJE online), though these relationships were largely attenuated when maternal BMI was included in the adjusted model. Estimates for maternal overweight and obesity were stable in models including maternal metabolic conditions (Supplementary Table 4).
In matched sibling analyses, there was no relationship between maternal BMI > 21 and ASD, nor was there risk associated with maternal overweight or obesity in categorical analyses (Table 3; Supplementary Figure 2, available as Supplementary data at IJE online). The mean change in BMI between pregnancies for mothers included in the matched sibling cohort was 0.92 kg/m2 (5th– 95th percentile: −1.1–5.1; see Supplementary Table 5 and Supplementary Figure 3, available as Supplementary data at IJE online) and for women in the full sibling cohort was 0.77 kg/m2 (−1.1–4.3).
Table 3.
Odds ratios and 95% confidence intervals for the association between maternal BMI and autism spectrum disorders in the full sibling (114 223 children born to 52 714 mothers) and matched sibling (4775 children born to 2066 mothers) cohorts, born in Sweden 1984–2007
| Full siblingsa |
Matched siblingsb |
|||||
|---|---|---|---|---|---|---|
| OR, 1 unit increase in maternal BMIc | OR, overweight vs normald | OR, obese vs normald | OR, 1 unit increase in maternal BMIc | OR, overweight vs normald | OR, obese vs normald | |
| ASD | 1.05 (1.04 – 1.07) | 1.24 (1.14 – 1.36) | 1.80 (1.59 – 2.04) | 0.99 (0.95 – 1.03) | 1.03 (0.84 – 1.25) | 1.06 (0.75 – 1.50) |
| ASD with ID | 1.06 (1.03 – 1.08) | 1.15 (0.96 – 1.37) | 1.76 (1.38 – 2.23) | 0.96 (0.89 – 1.04) | 0.72 (0.49 – 1.07) | 0.78 (0.40 – 1.53) |
| ASD without ID | 1.05 (1.04 – 1.07) | 1.28 (1.16 – 1.42) | 1.83 (1.59 – 2.11) | 0.99 (0.95 – 1.04) | 1.13 (0.90 – 1.43) | 1.15 (0.76 – 1.73) |
aCohort of full siblings included in the study population, evaluated using GEE models adjusted for sex, birth year of the child, sibling birth order, maternal age at the time of birth, paternal age at the time of birth, maternal country of birth, SES factors and parental history of psychiatric treatment. Results of the matched sibling comparison analyses are compared with results for all 114 223 full siblings in the cohort (those families that could potentially contribute to a matched sibling analysis) in order to guard against bias possibly introduced by excluding single children and half-siblings.
bCohort of ASD cases and their unaffected siblings, evaluated using conditional logistic regression models adjusted for sex, birth year of the child, sibling birth order, maternal age at the time of birth, paternal age at the time of birth.
cModels investigating maternal BMI ≥ 21, parameterized as a continuous variable.
dModels investigating maternal BMI, categorized according to WHO standards (Overweight: BMI ≥ 25 & <30; Obese: BMI ≥ 30) compared with normal maternal BMI (BMI ≥ 18.5 & <25) as the referent.
Paternal BMI and ASD risk
Maternal baseline BMI and paternal BMI at age 18 were weakly correlated (P = 0.07). Risk of ASD was elevated for underweight and obese fathers (Table 2). In continuous analysis, risk of ASD was increased for fathers with BMI below 20 and for fathers with BMI above 23 (Figure 3). Adjusting for maternal BMI somewhat attenuated the relationships between paternal BMI and ASD (Table 2). Similar risk patterns were observed after stratifying for ASD with and without intellectual disability (Figure 3; Table 2).
The relationship between paternal BMI and ASD was unchanged in sensitivity analyses with the exception that the risk of ASD without ID associated with elevated paternal BMI was only apparent in those born before 1998 (Supplementary Figure 1).
GWG and ASD risk
GWG was inversely associated with maternal baseline BMI (P = −0.06). However, the proportions of overweight (63.7%) and obese (53.8%) women who exceeded guidelines for GWG were greater compared with the proportions of normal weight (28.0%) and underweight (13.2%) women who exceeded guidelines.
Even in models accounting for baseline BMI, both insufficient and excessive GWG were independently associated with ASD (Table 4; Figure 4). The risk pattern was similar, with somewhat higher ORs, when restricted to women with a normal baseline BMI (Table 4; Figure 4). A similar risk pattern for ASD with and without ID was observed in these models (Table 4).
Table 4.
Odds ratios and 95% confidence intervals for the association between gestational weight gain (GWG) categories and ASD risk for children born in Sweden 1984–2007. Gestational weight gain categories were set using guidelines provided by the US Institute of Medicine and were conditioned on maternal baseline BMI
| Ideal GWG (reference) | Insufficient GWG | Excessive GWG | Every 2.3 kg (5 lb) increased | |||
|---|---|---|---|---|---|---|
| No. cases/non-cases | No. cases/non-cases | OR | No. cases/non-cases | OR | OR | |
| All mother/child pairsa | ||||||
| ASD | 737/47 250 | 502/27 331 | 1.17 (1.04 – 1.31) | 708/37 314 | 1.12 (1.01 – 1.25) | 1.03 (1.00 – 1.06) |
| ASD with ID | 195/47 250 | 139/27 331 | 1.19 (0.96 –1.48) | 182/37 314 | 1.16 (0.93 – 1.43) | |
| ASD without ID | 542/47 250 | 363/27 311 | 1.16 (1.01 – 1.32) | 526/37 314 | 1.11 (0.98 – 1.26) | |
| All mother/child pairs with normal maternal baseline BMIb | ||||||
| ASD | 139/37 111 | 118/22 917 | 1.22 (1.07 – 1.40) | 417/23 284 | 1.23 (1.08 – 1.40) | 1.05 (1.02 – 1.09) |
| ASD with ID | 527/37 111 | 409/22 917 | 1.31 (1.02 – 1.68) | 108/23 284 | 1.24 (0.96 – 1.60) | |
| ASD without ID | 388/37 111 | 291/22 917 | 1.19 (1.02 – 1.39) | 309/23 284 | 1.22 (1.05 – 1.42) | |
| Sibling cohortc | ||||||
| ASD | 167/225 | 106/136 | 1.21 (0.81 – 1.82) | 239/283 | 1.22 (0.85 – 1.76) | 1.04 (0.93 – 1.16) |
| Sibling cohort with normal maternal baseline BMI | ||||||
| ASD | 113/160 | 83/100 | 1.12 (0.68 – 1.84) | 114/123 | 1.48 (0.93 – 2.38) | 1.09 (0.90 – 1.31) |
aAnalysis conducted in all mother/child pairs with gestational weight gain data (113 469 children born to 96 390 mothers). GEE models, clustered on maternal ID, were adjusted for maternal BMI, gestational age at birth, sex, birth year of the child, parity, maternal age, paternal age, maternal country of birth, SES factors and parental history of psychiatric treatment.
bAnalysis restricted to mother/child pairs with normal baseline BMI values (18.5 ≤ BMI < 25; 84 655 children born to 73 501 mothers).
cAnalysis conducted in matched sibling pairs (1156 children born to 550 mothers). Conditional logistic regression models were adjusted for sex, birth year of the child, maternal age, paternal age and sibling birth order.
dTo allow comparison with a previous report,4 we calculated the risk of any ASD associated with every 5 lb (2.27 kg) of weight gained among women who met at least minimum GWG recommendations (i.e. those in the Ideal or Excessive GWG categories).
Figure 4.
Risk of offspring ASD associated with maternal gestational weight gain. The solid line indicates odds ratios estimated using a restricted cubic spline model with five knots. A gestational weight gain of 14 kg was used as the referent value. The 95% confidence interval is represented as grey bands. Due to the relatively small sample size for spline analysis, results are shown for weight gain between 7 and 22 kg, representing the 5th to 95th percentiles of the population distribution. (A) Association of maternal GWG with ASD risk among 113 469 mother/child pairs, including adjustment for maternal baseline BMI category. (B) Association of maternal GWG with ASD risk among 84 655 mother/child pairs with normal baseline BMI. OR estimates from a categorical model, similarly adjusted, are shown for comparison (dotted line; see Table 4). (C) Association of maternal GWG with ASD risk among 1156 children in the matched sibling cohort.
In matched sibling analysis, the ORs for risk of ASD associated with too much GWG among mothers with normal baseline BMI were higher compared with standard analysis (Table 4; Figure 4), although confidence intervals were wide. The mean change in GWG between pregnancies for mothers within the matched sibling cohort was −0.81 kg (5th–95th percentile: −11–8) and for women in the full sibling cohort was −0.51 kg (−8–5).
Discussion
In population-level analysis, increasing maternal baseline BMI above 21 was associated with greater ASD risk. Surprisingly, the results of the paternal BMI analysis and the sibling analysis suggest that these results are affected by residual confounding and that maternal BMI may be a proxy for other risk factors shared among members of the same family, such as genetics. On the other hand, excess risk of ASD was observed for both too little GWG as well as too much GWG, and these relationships were of consistent magnitude across all analyses.
Strengths and weaknesses
This is the largest study to date to examine the relationships of maternal BMI and GWG with ASD risk. We used multiple family-based study designs to assess the evidence for causality, as recommended for studies of the effects of developmental overnutrition on offspring health.6 Case-ascertainment bias was minimized by our validated case-finding approach. The prevalence of ASDs in our cohort is higher compared with ∼1–1.5% prevalence found elsewhere,23,24 though our recent analysis found that the prevalence of ASD in the SYC is highly comparable to prevalences reported by population monitoring programmes when comparing similar birth cohorts.10 We observed comparable relationships between maternal BMI and risk of ASD when comparing children born earlier and later in the cohort in our sensitivity analyses, suggesting that the changing prevalence over time does not explain our results.
Weaknesses include the limited availability of parental BMI and GWG data, potentially limiting the generalizability of the study. However, there were no notable differences between women with and without BMI data in the eligible population. This pattern of missing data is not likely to be due to differences in antenatal care-seeking patterns, as fewer than 5% of women in Sweden register at an antenatal clinic after 15 weeks or have fewer than three visits before delivery.25 There were no notable differences, other than year of birth of the index child, between mother/child pairs with GWG data and those without. Although fathers with BMI data (i.e. conscripted) were less likely to be immigrants and less likely to have a child with an immigrant than men not conscripted, these social factors were included in all adjusted models and not likely to influence internal validity of findings.
Another weakness of our study is that we have not considered developmental outcomes other than ASD. Several studies have found an inverse relationship between maternal BMI and children’s cognitive development,26–28 and one study showed that risk associated with maternal obesity was slightly higher for non-ASD developmental delays as for ASDs.3
We used maternal weight measured at the first antenatal visit as a proxy measure of pre-pregnancy BMI. Weight gain within the first trimester is on average low (0–2 kg).29,30 Additionally, the proportions of overweight and obesity within our study population agree well with reports among Swedish women in the general population during the same time period.12 Taken together, this indicates that BMI at first antenatal visit is a reasonable proxy for maternal BMI at the start of pregnancy.
We used paternal BMI data collected at the time of conscription to the Swedish military to determine whether maternal BMI associations with ASD were independent of other familial factors.7,8 Follow-up data on paternal BMI proximal to the birth of the index child were not available. On average, about 15 years elapsed between the time of paternal BMI measurements and the birth of the index child. However, paternal conscription BMI data are of high quality.31 These data also have the advantage that, in testing the hypothesis that genetic factors may explain some risk attributable to parental BMI, some potential confounding in modelling the relationship between paternal BMI and ASD risk was avoided, given that both BMI and offspring risk of ASD increase with parental age.18,32,33
Although the use of sibling comparison design can account for unmeasured familial confounders that standard adjustment may miss, there are limitations to this study design.34 Sibling comparison estimates, although less susceptible to shared confounding, are more severely biased by non-shared confounders than standard comparisons. Only those mother/child groups with a change in the exposure of interest between pregnancies will contribute to the risk estimate, and thus it is possible that there are residual non-shared confounders amongst offspring of women who substantially modify their weight between pregnancies. Use of a sibling comparison design by default limits the population included in the analysis, possibly affecting the power of the study. In our study, the power may be particularly limited for the categorical analyses for which only discordant matched sibling sets can contribute to the risk estimate; the continuous analyses are better -powered and more reliable. It is also important to remember that ASDs are spectrum disorders and that subclinical autistic traits are more common among siblings of affected children.35 Such similarities between affected and unaffected siblings would be expected to attenuate within-family associations.
Comparison with previous studies
Previous studies have reported an association between maternal pre-pregnancy obesity and offspring ASD risk.2,3 Dodds et al. compared mothers who weighed ≥90 kg at start of pregnancy with those who weighed less, in a population-based cohort study.2 Krakowiak et al. reported an association between maternal obesity, in the presence or absence of three other metabolic conditions, and ASD, in a population-based case-control study.3 Lyall et al, reported an association between maternal obesity at age 18 and ASD risk, but not with maternal BMI more proximal to the birth of the index child, in the National Nurses Health Study II.36 Among these studies, the risk attributable to maternal obesity is similar (on the order of 1.5–2 fold), and these agree with the results of our traditional analysis of maternal obesity.
On the other hand, Bilder et al. reported no association between maternal BMI in a population-based cohort or within a separate sibling comparison cohort.4 However, these were relatively small cohorts (128 and 228 cases, respectively), where adequate power may be lacking particularly for continuous analysis of BMI. Outside this study,4 no other study has previously employed a sibling comparison design to evaluate ASD risks associated with maternal BMI.
Surén et al. reported an association between maternal obesity and certain ASDs in a Norwegian cohort of the same order as the aforementioned studies, although this association was attenuated after adjustment for paternal BMI.5 The study may be limited in terms of the ability to detect an association by use of self-reported height and weight measures for both parents, use of ASD subtype diagnoses which have shown poor clinical reliability,37 and substantial case under-ascertainment. ASDs were diagnosed in only 0.45% of children (compared with ∼1–1.5% prevalence found elsewhere23,24).
In line with previous reports,3,38 we note that some maternal metabolic conditions were associated with offspring ASD risk. However, these associations were largely attenuated when maternal BMI was also considered in the model. The focus of our analysis is on the exploration of the relationship between maternal baseline BMI and GWG with offspring ASD risk. Elevated BMI is a core feature defining the metabolic syndrome and is strongly associated with development of metabolic pregnancy complications such as pre-eclampsia and gestational diabetes.39–41 Studying the full range of BMI and GWG values among mothers might better capture undiagnosed or subclinical metabolic dysfunction if an underlying metabolic dysfunction were driving the risk.
Consistent with previous reports,24 we found that excess maternal GWG was associated with increased ASD risk. We observed a similar risk pattern in our sibling cohort with regard to excessive weight gain. The risk attributable to every 2.3 kg (5 lb) of weight gained during pregnancy was smaller in our study compared with Bilder et al. who reported a 17% increased odds for every 2.3 kg (5 lb) of weight gain. A novel finding here is evidence of elevated risk associated with too little weight gain. Whereas the confidence intervals in the sibling comparison were wide, the ORs were of similar magnitude in both study designs, providing the first evidence that maternal undernutrition during the time of pregnancy may also contribute to ASD risk.
Interpretation and potential mechanisms
Previous studies have posited intra-uterine mechanisms mediated by circulating signalling molecules produced by maternal adipose tissue, such as leptin, sex hormones or pro-inflammatory cytokines, to explain the association between adiposity and ASD risk. The mechanisms underlying potential neurodevelopmental effects of maternal pre-pregnancy obesity and GWG need not be the same, and further investigation into such mechanisms is warranted. However, each of the proposed signalling imbalances would be more strongly influenced by the existing maternal adipose mass compared with the adipose tissue gained during the course of pregnancy,42–44 and are thus unlikely to fully explain the findings of this study regarding maternal baseline BMI.
The sibling analyses suggest that shared familial factors, such as socioeconomic status or genetic background, confound the association between maternal BMI and ASD risk at the population level. Given the quality of socioeconomic data, the small impact that inclusion of these factors made on risk estimates and the consistent results of the sensitivity analyses, these factors are not likely to explain the difference in results between the traditional analysis and the sibling analysis of maternal BMI. Both the sibling study and the study of paternal BMI suggest that confounding by genetic background potentially explains some of the risk attributable to maternal BMI in the traditional analysis. Genome-wide association studies (GWAS) implicate genetic variation in a number of neurogenesis and neuronal differentiation pathways as determinants of BMI.45 Some,46,47 but not all,48 studies have reported increased prevalence of overweight and obesity among children and adolescents with ASD compared with unaffected peers. Overlap in genetic determinants of BMI with genetic risk factors for ASD should be specifically examined in future studies. Additional mechanisms may exist to explain the perplexing difference in the results of the traditional analysis compared with the sibling analysis. For example, maternal BMI and diet during pregnancy affect the epigenome of the offspring.49–52 Differences in DNA methylation patterns have been detected between ASD cases and controls.53,54 Since many epigenetic markers are dependent on the underlying genetic code,55 risks mediated by such a mechanism could be difficult to detect using a matched sibling design. Finally, it is possible that if the relationship between maternal BMI and ASD risk were mediated by a molecular factor that is responsive to an obesogenic environment, and thus correlated to maternal BMI in general, but was also influenced by genetic factors, and thus much more strongly correlated within a woman over time compared with differences between women, that we might observe a similar attenuation of the results of the traditional analysis in the matched sibling analysis. The role of such mediating factors in sibling analyses remains to be explored.
The association of offspring ASD with paternal BMI at age 18 also suggests the influence of genetic factors in terms of the association of parental BMI and ASD status. Elevated BMI in males has been associated with increased DNA fragmentation,56,57 thus leading to the possibility that obese fathers may be more likely to pass on de novo mutations that confer risk for ASD.58 Evidence from animal and human studies shows that paternal diet, BMI and preconceptual stress experiences can also affect the methylation pattern of the offspring epigenome.50,59–61
This is the largest study to date exploring the relationship of maternal BMI, paternal BMI and GWG with risk of offspring ASD. Our results indicate that maternal weight gain during pregnancy is consequential for offspring ASD risk. However, the underlying mechanisms connecting GWG with ASD remain unclear, so that specific public health recommendations beyond focusing on healthy GWG are not yet possible. Our results also indicate that maternal and paternal BMI may also be proxy markers for other familial risk factors, including potentially a shared genetic risk. In order to move forward and understand the mechanisms underlying the associations between parental BMI, GWG and offspring ASD risk, future studies employing analysis of biological samples for nutritional, genetic and epigenetic markers, as well as including measures of parental BMI and GWG, are necessary.
Supplementary Data
Supplementary data are available at IJE online.
Funding
This work was supported by Autism Speaks (http://www.autismspeaks.org/; Basic and Clinical Grant #7618) and the Swedish Research Council (http://www.vr.se/; Grant # 2012‐2264). The Open Access fee was funded using Swedish Research Council Grant # 2012-2264. The data linkages and staff costs have also been supported by grants from the: Stockholm County Council (http://www.sll.se/; Grant # 2007008); Swedish Council for Working Life and Social Research (http://www.forte.se/; Grant # 2007‐2064); Swedish Research Council (http://www.vr.se/; Grant # 523‐2010‐1052); and Swedish Regional agreement on medical training and clinical research (ALF). No funder had any role in the study design; data collection, analysis, or interpretation; the writing of the report; or the decision to submit the article for publication. No data sharing is available.
Author contributions
R.G., C.D. and B.K.L. had the research idea, and D.R., C.M., T.F., H.K. and S.I. helped with its development. R.G. conducted the statistical analysis and wrote the first and subsequent drafts of the paper with important intellectual input from all co-authors. All authors had full access to the data and the statistical reports and tables arising from the data analysis, and take responsibility for the integrity of the data and accuracy of the data analysis. All authors have approved the final version of the manuscript submitted for publication. R.G. and C.D. act as guarantors, and assure that this manuscript is an honest, accurate and transparent account of the analysis undertaken.
Conflict of interest: The authors have declared that no competing interests exist.
Supplementary Material
References
- 1.Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377: 557–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dodds L, Fell DB, Shea S, Armson BA, Allen AC, Bryson S. The role of prenatal, obstetric and neonatal factors in the development of autism. J Autism Dev Disord 2011;41:891–902. [DOI] [PubMed] [Google Scholar]
- 3.Krakowiak P, Walker CK, Bremer AA, et al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 2012;129:e1121–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bilder DA, Bakian AV, Viskochil J, et al. Maternal prenatal weight gain and autism spectrum disorders. Pediatrics 2013;132:e1276–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Suren P, Gunnes N, Roth C, et al. Parental obesity and risk of autism spectrum disorder. Pediatrics 2014;35:e1128–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lawlor DA. The Society for Social Medicine John Pemberton Lecture 2011. Developmental overnutrition – an old hypothesis with new importance? Int J Epidemiol 2013;42:7–29. [DOI] [PubMed] [Google Scholar]
- 7.Davey Smith G. Assessing intrauterine influences on offspring health outcomes: can epidemiological studies yield robust findings?. Basic Clin Pharmacol Toxicol 2008;102:245–56. [DOI] [PubMed] [Google Scholar]
- 8.Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 2010;21:383–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Idring S, Rai D, Dal H, et al. Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and validity. PloS One 2012;7:e41280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Idring S, Lundberg M, Sturm H, et al. Changes in prevalence of autism spectrum disorders in 2001–2011: Findings from the Stockholm Youth Cohort. J Autism Dev Disord 2014, Dec 5. PMID: 25475364. [Epub ahead of print.] [DOI] [PubMed] [Google Scholar]
- 11.National Board on Health and Welfare. The Swedish Medical Birth Register–- A Summary of Content and Quality. Stockholm: National Board on Health and Welfare, 2003. [Google Scholar]
- 12.Berg C, Rosengren A, Aires N, et al. Trends in overweight and obesity from 1985 to 2002 in Goteborg, West Sweden. Int J Obes (Lond) 2005;29:916–24. [DOI] [PubMed] [Google Scholar]
- 13.Brynhildsen J, Sydsjo A, Norinder E, Selling KE, Sydsjo G. Trends in body mass index during early pregnancy in Swedish women 1978–2001. Public Health 2006;120:393–99. [DOI] [PubMed] [Google Scholar]
- 14.WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry. Physical Status : the Use And Interpretation Of Anthropometry : Report of a WHO Expert Committee. Geneva: World Health Organization, 1995. [PubMed] [Google Scholar]
- 15.Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 2006;93:269–74. [DOI] [PubMed] [Google Scholar]
- 16.Rasmussen KM, Yaktine AL, Institute of Medicine (U.S.). Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy : Reexamining the Guidelines. Washington, DC: National Academies Press, 2009. [PubMed] [Google Scholar]
- 17.Rai D, Lewis G, Lundberg M, et al. Parental socioeconomic status and risk of offspring autism spectrum disorders in a Swedish population-based study. J Am Acad Child Adolesc Psychiatry 2012;51:467–76. [DOI] [PubMed] [Google Scholar]
- 18.Idring S, Magnusson C, Lundberg M, et al. Parental age and the risk of autism spectrum disorders: findings from a Swedish population-based cohort. Int J Epidemiol 2014;43:107–15. [DOI] [PubMed] [Google Scholar]
- 19.Nicola O, Sander G. A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J 2011;11:1–29. [Google Scholar]
- 20.Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004;61:618–27. [DOI] [PubMed] [Google Scholar]
- 21.Lee BK, Gardner RM, Dal H, et al. Brief report: maternal smoking during pregnancy and autism spectrum disorders. J Autism Dev Disord 2012;42:2000–05. [DOI] [PubMed] [Google Scholar]
- 22.Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013;346:f2059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Division of Birth Defects NCoBDaDD. Autism Spectrum Disorders Data & Statistics. 2013. 6/27/2013 http://www.cdc.gov/ncbddd/autism/documents/asd_prevalence_table_2013.pdf (15 October 2013, date last accessed).
- 24.Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014;63:1–21. [PubMed] [Google Scholar]
- 25.Darj E, Lindmark G. [Not all women use maternal health services. Language barriers and fear of the examination are common.] Lakartidningen 2002;99:41–44. [PubMed] [Google Scholar]
- 26.Basatemur E, Gardiner J, Williams C, Melhuish E, Barnes J, Sutcliffe A. Maternal prepregnancy BMI and child cognition: a longitudinal cohort study. Pediatrics 2013;131:56–63. [DOI] [PubMed] [Google Scholar]
- 27.Casas M, Chatzi L, Carsin AE, et al. Maternal pre-pregnancy overweight and obesity, and child neuropsychological development: two Southern European birth cohort studies. Int J Epidemiol 2013;42:506–17. [DOI] [PubMed] [Google Scholar]
- 28.Hinkle SN, Schieve LA, Stein AD, Swan DW, Ramakrishnan U, Sharma AJ. Associations between maternal prepregnancy body mass index and child neurodevelopment at 2 years of age. Int J Obes (Lond) 2012;36:1312–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fattah C, Farah N, Barry SC, O'Connor N, Stuart B, Turner MJ. Maternal weight and body composition in the first trimester of pregnancy. Acta Obstet Gynecol Scand 2010;89:952–55. [DOI] [PubMed] [Google Scholar]
- 30.Abrams B, Carmichael S, Selvin S. Factors associated with the pattern of maternal weight gain during pregnancy. Obstet Gynecol 1995;86:170–76. [DOI] [PubMed] [Google Scholar]
- 31.Neovius M, Sundstrom J, Rasmussen F. Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study. BMJ 2009;338:b496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nooyens AC, Visscher TL, Verschuren WM, et al. Age, period and cohort effects on body weight and body mass index in adults: The Doetinchem Cohort Study. Public Health Nutr 2009;12:862–70. [DOI] [PubMed] [Google Scholar]
- 33.Droyvold WB, Nilsen TI, Kruger O, et al. Change in height, weight and body mass index: Longitudinal data from the HUNT Study in Norway. Int J Obes (Lond) 2006;30:935–39. [DOI] [PubMed] [Google Scholar]
- 34.Frisell T, Oberg S, Kuja-Halkola R, Sjolander A. Sibling comparison designs: bias from non-shared confounders and measurement error. Epidemiology 2012;23:713–20. [DOI] [PubMed] [Google Scholar]
- 35.Constantino JN, Lajonchere C, Lutz M, et al. Autistic social impairment in the siblings of children with pervasive developmental disorders. Am J Psychiatry 2006;163:294–96. [DOI] [PubMed] [Google Scholar]
- 36.Lyall K, Pauls DL, Santangelo SL, Spiegelman D, Ascherio A. Maternal early life factors associated with hormone levels and the risk of having a child with an autism spectrum disorder in the Nurses Health Study II. J Autism Dev Disord 2011;41:618–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lord C, Petkova E, Hus V, et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry 2012;69:306–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009;195:7–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Papakonstantinou E, Lambadiari V, Dimitriadis G, Zampelas A. Metabolic syndrome and cardiometabolic risk factors. Curr Vasc Pharmacol 2013;11:858–79. [DOI] [PubMed] [Google Scholar]
- 40.Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 2013;347:f6564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth 2010;10:56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Maple-Brown L, Ye C, Hanley AJ, et al. Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status. J Clin Endocrinol Metab 2012;97:4148–55. [DOI] [PubMed] [Google Scholar]
- 43.Wuu J, Hellerstein S, Lipworth L, et al. Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev 2002;11:283–93. [DOI] [PubMed] [Google Scholar]
- 44.Kaijser M, Jacobsen G, Granath F, Cnattingius S, Ekbom A. Maternal age, anthropometrics and pregnancy oestriol. Paediatr Perinat Epidemiol 2002;16:149–53. [DOI] [PubMed] [Google Scholar]
- 45.Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Egan AM, Dreyer ML, Odar CC, Beckwith M, Garrison CB. Obesity in young children with autism spectrum disorders: prevalence and associated factors. Child Obes 2013;9:125–31. [DOI] [PubMed] [Google Scholar]
- 47.Phillips KL, Schieve LA, Visser S, et al. Prevalence and impact of unhealthy weight in a national sample of US adolescents with autism and other learning and behavioral disabilities. Matern Child Health J 2014;18:1964–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Curtin C, Bandini LG, Perrin EC, Tybor DJ, Must A. Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart review. BMC Pediatr 2005;5:48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Godfrey KM, Sheppard A, Gluckman PD, et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011;60:1528–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Soubry A, Murphy SK, Wang F, et al. Newborns of obese parents have altered DNA methylation patterns at imprinted genes. Int J Obes (Lond) 2015;39:650–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Liu X, Chen Q, Tsai HJ, et al. Maternal preconception body mass index and offspring cord blood DNA methylation: Exploration of early life origins of disease. Environ Mol Mutagen 2014;55:223–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Dominguez-Salas P, Moore SE, Baker MS, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Communications 2014;5:3746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry 2014;19:862–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Nguyen A, Rauch TA, Pfeifer GP, Hu VW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 2010;24:3036–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Gibbs JR, van der Brug MP, Hernandez DG, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet 2010;6:e1000952. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kort HI, Massey JB, Elsner CW, et al. Impact of body mass index values on sperm quantity and quality. J Androl 2006;27:450–52. [DOI] [PubMed] [Google Scholar]
- 57.Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril 2010;93:2222–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010;466:368–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Lambrot R, Xu C, Saint-Phar S, et al. Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes. Nature Communications 2013;4:2889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Soubry A, Schildkraut JM, Murtha A, et al. Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med 2013;11:29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Dias BG, Ressler KJ. Parental olfactory experience influences behavior and neural structure in subsequent generations. Nat Neurosci 2014;17:89–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




